✦ LIBER ✦

Combination of a CpG-oligodeoxynucleotide and a topoisomerase I inhibitor in the therapy of human tumour xenografts

✍ Scribed by A. Balsari; M. Tortoreto; D. Besusso; G. Petrangolini; L. Sfondrini; R. Maggi; S. Ménard; G. Pratesi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

148 In vivo preclinical evaluation of th

✍ F. Némati; V. Diéras; L. de Plater; A. Berniard; F. Assayag; C. Elbaz; J.J. Font 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

In vivo antitumor activity of S16020, a

✍ Gilles Vassal; Jean-Louis Merlin; Marie-José Terrier-Lacombe; Jacques Grill; Fab 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 260 KB

In vivo antitumor activity of F 11782, a

✍ A. Kruczynski; C. Ricome; W.R. Waud; B.T. Hill 📂 Article 📅 2002 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 441 KB

Radiation enhancement by the combined us

✍ Jae-Sung Kim; George P. Amorino; Hongryull Pyo; Qianwen Cao; Hak Choy 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 147 KB

CpG oligodeoxynucleotide and montanide I

✍ Jiling Ren; Liang Yang; Haifei Xu; Yongsheng Zhang; Min Wan; Guoying Liu; Lixia 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 380 KB

535 POSTER AZD2171, a highly potent, ora

✍ K. Williams; A. Shannon; B. Telfer; M. Babur; I. Stratford; S. Wedge 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB